Horizon Therapeutics

TEPEZZA

Manufacturer:

Horizon Therapeutics

Tepezza HCPCS:

J3241

HCPCS Code Descriptor:

Injection, teprotumumab-trbw, 10 mg

Category:

J Code

Tepezza NDCs:

75987-0130-15

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

75987-0130-15

About Tepezza:

TEPEZZA is an Opthalmic drug manufactured by Horizon Therapeutics and administered via the Intravenous route of administration. The J Code: J3241 is aligned to the drug TEPEZZA.

ACCESS PRICING AND MORE BY REGISTERING

J3241 Added Date:

October 1, 2020

J3241 Effective Date:

October 1, 2020

J3241 Termination Date:

HCPCS Active

Tepezza billing and coding information can be found through Horizon Therapeutics at the link below:
Tepezza patient assistance information can be found through Amgen at the URL: https://www.tepezza.com/
TEPEZZA prescribing information can be found at the link below:
Information regarding TEPEZZA’s side effects can be found at MedlinePlus